CEO & President, Ajinomoto Bio-Pharma Services Europe

Mark Cassidy is an experienced Life Science and Fine Chemical executive with a successful track record of strategy development and implementation. He is responsible for leading the global business strategy of Ajinomoto Bio-Pharma Services to support organic, as well as inorganic growth for the CDMO.

Dr. Cassidy has almost 30 years’ experience working within leading industrial corporations, such as Merck, Dow Chemical, Sigma Aldrich, Piramal Healthcare and Ajinomoto OmniChem, during which time he has held leadership positions in Sales, Marketing, R&D, Operations & General Management.

During his career, Dr. Cassidy has worked in areas ranging from the leadership of entrepreneurial teams in the successful development & commercialization of novel IP based pharmaceutical products & services, through to the implementation of strategic changes to markedly improve the customer service and financial performance of contract manufacturing businesses.

Dr. Cassidy has broad international business experience, having led multi-site and multicultural business teams for over 20 years. During this period, he has lived and worked in the UK, Switzerland, Germany and USA.


  • Strategy development and implementation
  • People leadership.
  • Mergers, Acquisitions & Integrations
  • Developing and launching new products, technologies and service offerings
  • Negotiating complex, multi-million $ B-2-B deals.